EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Precise identification of somatic and germline variants in the absence of matched normal samples

Hui Li, Lu Meng, Hongke Wang iD, Liang Cui, Heyu Sheng, Peiyan Zhao, Shuo Hong, Xinhua Du, Shi Yan, Yun Xing, Shicheng Feng, Yan Zhang und 9 weitere

Briefings in Bioinformatics · 2024

DOI: 10.1093/bib/bbae677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2024. Verfasst von Hui Li und 20 weiteren Autor:innen. Beteiligte Einrichtung: The Medical Oncology Translational Research Laboratory, Jilin Provincial Key Laboratory of Molecular Diagnostics for Lung Cancer, Jilin Cancer Hospit…. Hauptthemen laut MEDLINE: Germ-Line Mutation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science and Technology Planning Project of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Somatic variants play a crucial role in the occurrence and progression of cancer. However, in the absence of matched normal controls, distinguishing between germline and somatic variants becomes challenging in tumor samples. The existing tumor-only genomic analysis methods either suffer from limited performance or insufficient interpretability due to an excess of features. Therefore, there is an urgent need for an alternative approach that can address these issues and have practical implications. Here, we presented OncoTOP, a computational method for genomic analysis without matched normal samples, which can accurately distinguish somatic mutations from germline variants. Reference sample analysis revealed a 0% false positive rate and 99.7% reproducibility for variant calling. Assessing 2864 tumor samples across 18 cancer types yielded a 99.8% overall positive percent agreement and a 99.9% positive predictive value. OncoTOP can also accurately detect clinically actionable variants and subclonal mutations associated with drug resistance. For the prediction of mutation origins, the positive percent agreement stood at 97.4% for predicting somatic mutations and 95.7% for germline mutations. High consistency of tumor mutational burden (TMB) was observed between the results generated by OncoTOP and tumor-normal paired analysis. In a cohort of 97 lung cancer patients treated with immunotherapy, TMB-high patients had prolonged PFS (P = .02), proving the reliability of our approach in estimating TMB to predict therapy response. Furthermore, microsatellite instability status showed a strong concordance (97%) with polymerase chain reaction results, and leukocyte antigens class I subtypes and homozygosity achieved an impressive concordance rate of 99.3% and 99.9% respectively, compared to its tumor-normal paired analysis. Thus, OncoTOP exhibited high reliability in variant calling, mutation origin prediction, and biomarker estimation. Its application will promise substantial advantages for clinical genomic testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationHumansNeoplasmsReproducibility of ResultsMutationComputational BiologyGenomicsLung NeoplasmsBiomarkers, Tumor

Stichwörter der Autor:innen

DNA sequencingOncoTOPbioinformaticsbiomarkercancer genomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • The Medical Oncology Translational Research Laboratory, Jilin Provincial Key Laboratory of Molecular Diagnostics for Lung Cancer, Jilin Cancer Hospital, No. 1066, Jinhu Road, Changchun, 130012, China.
  • Geneplus-Beijing Institute, 9th Floor, No. 6 Building, Peking University Medical Industrial Park, Zhongguancun Life Science Park, Beijing, 102206, China.
  • College of Future Technology, Peking University, No. 5 Yiheyuan Road, Beijing, 100871, China.
  • The Department of Medical Oncology, Jilin Cancer Hospital, No. 1066, Jinhu Road, Changchun, 130012, China.

ORCID-Profile: Hongke Wang

Förderung

  • Science and Technology Planning Project of Jilin Province

Zitieren

APA

Li, H., Meng, L., Wang, H., Cui, L., Sheng, H., Zhao, P., Hong, S., Du, X., Yan, S., Xing, Y., Feng, S., Zhang, Y., Fang, H., Bai, J., Liu, Y., Lan, S., Liu, T., Guan, Y., Xia, X., …, & Cheng, Y. (2024). Precise identification of somatic and germline variants in the absence of matched normal samples. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbae677

Vancouver

Li H, Meng L, Wang H, Cui L, Sheng H, Zhao P, et al. Precise identification of somatic and germline variants in the absence of matched normal samples. Briefings in Bioinformatics. 2024. doi:10.1093/bib/bbae677

BibTeX
@article{Li2024,
  author = {Li, Hui and Meng, Lu and Wang, Hongke and Cui, Liang and Sheng, Heyu and Zhao, Peiyan and Hong, Shuo and Du, Xinhua and Yan, Shi and Xing, Yun and Feng, Shicheng and Zhang, Yan and Fang, Huan and Bai, Jing and Liu, Yan and Lan, Shaowei and Liu, Tao and Guan, Yanfang and Xia, Xuefeng and Yi, Xin and Cheng, Ying},
  title = {Precise identification of somatic and germline variants in the absence of matched normal samples},
  journal = {Briefings in Bioinformatics},
  year = {2024},
  doi = {10.1093/bib/bbae677}
}
Kostenlos starten →